feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Idogen: IDO 8 granted orphan drug designation in the US
Research Note
2018-09-26
08:52
Idogen announced today that the FDA has granted the IDO 8 project orphan drug designation.
MS
Mathias Spinnars
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans